Rockefeller Capital Management L.P. grew its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 34.0% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 88,893 shares of the biopharmaceutical company’s stock after purchasing an additional 22,559 shares during the quarter. [...]